Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma.
Sunaga N, Kaira K, Tomizawa Y, Shimizu K, Imai H, Takahashi G, Kakegawa S, Ohtaki Y, Nagashima T, Kasahara N, Kawashima O, Hisada T, Saito R, Yamada M. Sunaga N, et al. Among authors: shimizu k. Br J Cancer. 2014 Apr 15;110(8):2047-53. doi: 10.1038/bjc.2014.110. Epub 2014 Feb 27. Br J Cancer. 2014. PMID: 24577055 Free PMC article.
Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations.
Masuda T, Imai H, Kuwako T, Miura Y, Yoshino R, Kaira K, Shimizu K, Sunaga N, Tomizawa Y, Ishihara S, Mogi A, Hisada T, Minato K, Takise A, Saito R, Yamada M. Masuda T, et al. Among authors: shimizu k. Clin Transl Oncol. 2015 Sep;17(9):702-9. doi: 10.1007/s12094-015-1297-8. Epub 2015 May 20. Clin Transl Oncol. 2015. PMID: 25990507
Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer.
Imai H, Sunaga N, Shimizu Y, Kakegawa S, Shimizu K, Sano T, Ishizuka T, Oyama T, Saito R, Minna JD, Mori M. Imai H, et al. Among authors: shimizu k, shimizu y. Int J Immunopathol Pharmacol. 2010 Jan-Mar;23(1):153-64. doi: 10.1177/039463201002300114. Int J Immunopathol Pharmacol. 2010. PMID: 20378003 Free PMC article.
Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
Sunaga N, Kaira K, Imai H, Shimizu K, Nakano T, Shames DS, Girard L, Soh J, Sato M, Iwasaki Y, Ishizuka T, Gazdar AF, Minna JD, Mori M. Sunaga N, et al. Among authors: shimizu k. Oncogene. 2013 Aug 22;32(34):4034-42. doi: 10.1038/onc.2012.402. Epub 2012 Sep 10. Oncogene. 2013. PMID: 22964644 Free PMC article.
[Surgical resection of T3 and T4 lung cancer].
Kamiyoshihara M, Kakegawa S, Kawashima O, Sugano M, Nagashima T, Otani Y, Shimizu K, Nakano T, Ibe T, Morishita Y. Kamiyoshihara M, et al. Among authors: shimizu k. Kyobu Geka. 2005 Oct;58(11):954-8. Kyobu Geka. 2005. PMID: 16235842 Japanese.
7,344 results